Trial Profile
Multicenter, retrospective trial of tocilizumab on adult onset still's disease in Korean population.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Adult-onset Still's disease
- Focus Therapeutic Use
- 08 Feb 2016 New trial record